New Stomach Cancer Drug Doubles Survival Time in Clinical Trial
An experimental AstraZeneca drug doubled median survival from five to 10 months in a trial involving 532 patients with advanced stomach cancer.
Shlomi Diaz
26.10.26 | 10:40
An experimental AstraZeneca drug doubled median survival from five to 10 months in a trial involving 532 patients with advanced stomach cancer.
Shlomi Diaz
26.10.26 | 10:40
Researchers have developed an AI tool that estimates cancer survival from a single face photo. The results reveal surprising clues about our health.
Yitzchak Eitan
22.10.26 | 16:39
Researchers exploring Antarctica discovered a marine bacterium whose natural compounds damaged melanoma cells in laboratory tests, raising hopes for future cancer treatments.
Shira Dabush
09.07.26 | 11:29
After losing a close family friend to pancreatic cancer, teenager Jack Andraka began searching for a better way to detect the disease early.
Yehosef Yavetz
27.05.26 | 20:54